Search research articles
Contact Us
Filters
Showing results (11-20 of 137) with videos related to
Page
of 14
Sort By:
Journal of Oncology
|
September 10, 2011
Angiogenesis in acute myeloid leukemia and opportunities for novel therapies
Angelica Trujillo, Christie McGee, Christopher R Cogle
JAMA
|
November 14, 2022
Medicaid's Moment for Protecting and Promoting Women's Health
Mohammad Hussain Dar, Charissa Fotinos, Christopher R Cogle
Leukemia Research
|
September 25, 2017
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
Roger A Fleischman, Shannon S Stockton, Christopher R Cogle
Health Affairs Scholar
|
September 10, 2024
Integrating firearm storage and safety devices into health care
Christopher R Cogle, Anirudh B Venkatesh, Jaclyn M Hall
Biochemical and Biophysical Research Communications
|
April 7, 2015
Prevention of EBV lymphoma development by oncolytic myxoma virus in a murine xenograft model of post-transplant lymphoproliferative disease
Manbok Kim, Masmudur M Rahman, Christopher R Cogle, et al.
Healthcare (Basel, Switzerland)
|
February 25, 2022
Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System
Amar H Kelkar, Jing Zhao, Shu Wang, et al.
Plos One
|
August 21, 2012
Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells
Eric Bartee, Amy Meacham, Elizabeth Wise, et al.
Cytokine & Growth Factor Reviews
|
March 10, 2010
Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus
Masmudur M Rahman, Gerard J Madlambayan, Christopher R Cogle, et al.
The Oncologist
|
October 15, 2015
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Christopher R Cogle, Bart L Scott, Thomas Boyd, et al.
Viruses
|
March 25, 2016
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
Nancy Y Villa, Masmudur M Rahman, Grant McFadden, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 137) with videos related to
Sort By:
Page
of 14
Journal of Oncology
|
September 10, 2011
Angiogenesis in acute myeloid leukemia and opportunities for novel therapies
Angelica Trujillo, Christie McGee, Christopher R Cogle
JAMA
|
November 14, 2022
Medicaid's Moment for Protecting and Promoting Women's Health
Mohammad Hussain Dar, Charissa Fotinos, Christopher R Cogle
Leukemia Research
|
September 25, 2017
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
Roger A Fleischman, Shannon S Stockton, Christopher R Cogle
Health Affairs Scholar
|
September 10, 2024
Integrating firearm storage and safety devices into health care
Christopher R Cogle, Anirudh B Venkatesh, Jaclyn M Hall
Biochemical and Biophysical Research Communications
|
April 7, 2015
Prevention of EBV lymphoma development by oncolytic myxoma virus in a murine xenograft model of post-transplant lymphoproliferative disease
Manbok Kim, Masmudur M Rahman, Christopher R Cogle, et al.
Healthcare (Basel, Switzerland)
|
February 25, 2022
Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System
Amar H Kelkar, Jing Zhao, Shu Wang, et al.
Plos One
|
August 21, 2012
Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells
Eric Bartee, Amy Meacham, Elizabeth Wise, et al.
Cytokine & Growth Factor Reviews
|
March 10, 2010
Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus
Masmudur M Rahman, Gerard J Madlambayan, Christopher R Cogle, et al.
The Oncologist
|
October 15, 2015
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia
Christopher R Cogle, Bart L Scott, Thomas Boyd, et al.
Viruses
|
March 25, 2016
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
Nancy Y Villa, Masmudur M Rahman, Grant McFadden, et al.
Page
of 14